RHJA
CDNA icon

Rice Hall James & Associates’s CareDx CDNA Stock Holding History

Rice Hall James & Associates’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,923
Closed -$1.36M – 310
2021
Q4 		$1.36M Sell
29,923
-1,000
-3% -$52.2K 0.05% 232
2021
Q3 		$1.96M Buy
30,923
+124
+0.4% +$9.44K 0.07% 207
2021
Q2 		$2.82M Sell
30,799
-1,449
-4% -$115K 0.1% 159
2021
Q1 		$2.2M Sell
32,248
-51,129
-61% -$3.97M 0.07% 204
2020
Q4 		$6.04M Sell
83,377
-129,849
-61% -$7.52M 0.21% 87
2020
Q3 		$8.09M Sell
213,226
-77,486
-27% -$2.62M 0.33% 67
2020
Q2 		$10.3M Sell
290,712
-68,145
-19% -$1.94M 0.44% 60
2020
Q1 		$7.83M Sell
358,857
-178,086
-33% -$3.99M 0.44% 70
2019
Q4 		$11.6M Buy
+536,943
New +$12.3M 0.39% 99

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Rice Hall James & Associates's CDNA Position: Q1 2022 in Review

Rice Hall James & Associates sold out of CareDx (CDNA) in Q1 2022, closing a stake of 29,923 shares — an estimated $1.36M sold.

Rice Hall James & Associates first reported a position in CDNA in Q4 2019 and held it in 9 quarters. The position peaked at $11.6M in Q4 2019. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Rice Hall James & Associates reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 29,923 CareDx shares in Q1 2022, an estimated $1.36M.
  • Rice Hall James & Associates first reported a position in CareDx in Q4 2019 and held it in 9 quarters.
  • Rice Hall James & Associates's CareDx position peaked at $11.6M in Q4 2019.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.